308 related articles for article (PubMed ID: 10882845)
21. Mechanism of action of St John's wort in depression : what is known?
Butterweck V
CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of glutamate, aspartate and gamma-aminobutyric acid release from synaptosomes by hyperforin.
Chatterjee SS; Biber A; Weibezahn C
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S11-9. PubMed ID: 11518057
[TBL] [Abstract][Full Text] [Related]
23. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
[TBL] [Abstract][Full Text] [Related]
24. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
26. St John's wort: Prozac from the plant kingdom.
Di Carlo G; Borrelli F; Ernst E; Izzo AA
Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157
[TBL] [Abstract][Full Text] [Related]
27. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin.
Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE
Behav Brain Res; 2009 May; 199(2):334-9. PubMed ID: 19136030
[TBL] [Abstract][Full Text] [Related]
28. Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity.
Jensen AG; Hansen SH; Nielsen EO
Life Sci; 2001 Feb; 68(14):1593-605. PubMed ID: 11263672
[TBL] [Abstract][Full Text] [Related]
29. [Mechanism of action of St. Johns wort extract].
Müller WE; Singer A; Wonnemann M
Praxis (Bern 1994); 2000 Dec; 89(50):2111-21. PubMed ID: 11155494
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort.
Kiewert C; Buchholzer ML; Hartmann J; Chatterjee SS; Klein J
Neurosci Lett; 2004 Jul; 364(3):195-8. PubMed ID: 15196674
[TBL] [Abstract][Full Text] [Related]
32. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel W; Schober F; Mannel M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
[TBL] [Abstract][Full Text] [Related]
33. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
[TBL] [Abstract][Full Text] [Related]
34. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters.
Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075
[TBL] [Abstract][Full Text] [Related]
35. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
Martínez-Poveda B; Quesada AR; Medina MA
Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
[TBL] [Abstract][Full Text] [Related]
36. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study.
Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC
J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952
[TBL] [Abstract][Full Text] [Related]
37. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
38. Hyperforin.
Beerhues L
Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
[TBL] [Abstract][Full Text] [Related]
39. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
40. Optimization of Light Intensity, Temperature, and Nutrients to Enhance the Bioactive Content of Hyperforin and Rutin in St. John's Wort.
Kuo CH; Chou YC; Liao KC; Shieh CJ; Deng TS
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]